SB 152 Connecticut Senate · 2025 Regular Session

AN ACT ADOPTING THE HUMAN CELL PRODUCT LABELING ACT.

SB 152 requires businesses selling products developed or tested using human cells to provide a clear warning to consumers. This warning must state that human cells were used and include a website address disclosing the cell origin, collection method, and scientific name of the cell base. The law directly affects businesses selling such products in the state and imposes civil or criminal penalties for failing to provide this disclosure. It adopts the Human Cell Product Labeling Act to ensure transparency about human cell-derived products.
Bill status in committee 1 of 4 stages cleared
Introduction
Jan 2025
Committee Review
Floor Vote
Governor
Introduced Jan 8, 2025 Last action Jan 8, 2025
Floor votes

How they voted

No floor votes recorded yet.
Full legislative history

Actions timeline

Total actions
1
Key actions
0
Committee
1
Jan 8, 2025
Committee
REF. TO JOINT COMM. ON General Law
upper
0 primary · 0 co-sponsors

Sponsors

No sponsor information available.